Skip to main content
NK

NÖK Therapeutics

Cranberry Twp, United States
Last funding
$1.1M
SeedOct 2025

NÖK Therapeutics is a biotechnology company that offers NK cell therapies to deepen remissions and drive cures in high-relapse cancers.

About NÖK Therapeutics

How much funding has NÖK Therapeutics raised?

NÖK Therapeutics has raised $1.1M in total funding. The most recent round was Seed. The last funding was announced in October 2025.

Where is NÖK Therapeutics headquartered?

NÖK Therapeutics is headquartered in Cranberry Twp, United States.

What does NÖK Therapeutics do?

NÖK Therapeutics is a biotechnology company that offers NK cell therapies to deepen remissions and drive cures in high-relapse cancers.

What stage is NÖK Therapeutics at?

NÖK Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"NÖK Therapeutics — Funding & Investors." VCBacked, October 24, 2025, https://www.vcbacked.co/company/nk-therapeutics. Accessed November 17, 2026.
APA
VCBacked. (2025). NÖK Therapeutics — Funding & Investors. Retrieved November 17, 2026, from https://www.vcbacked.co/company/nk-therapeutics
Wikipedia (cite web)
{{cite web |title=NÖK Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nk-therapeutics |website=VCBacked |access-date=November 17, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at NÖK Therapeutics? Request a listing update

Founder contacts
m***@noktx.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →